Doug DiRuggiero discusses oral JAK inhibitors for patients with atopic dermatitis and how these new agents will benefit patients with AD.
Doug DiRuggiero discusses oral JAK inhibitors for patients with atopic dermatitis and how these new agents will benefit patients with AD.